5Ryden G, Andersson RG, Berg G. Binding of four oxy tocin analogues to myometrial oxytocin and arginine vas opressin binding sites in pregnant women [J]. Gyneco logic and Obstetric Investigation, 1990, 29(1) : 6-9.
6Ekstrom P, Akerlund M, Forsling M, et al. Stimulation of vasopressin release in women with primary dysmen orrhea and after oral contraceptive treatment effect on uterine contractility[J]. Br J Obstet Gynaecol, 1992,99 (8):680-684.
7Akerlund M. The role of oxytocin and vasopressin in the initiation of preterm and term labour as well as primary dysmenorrhea[J]. Regul Dept, 1993,45 ( 1 ) :187-191.
8Dawood MY,Khan Dawood FS. Differential suppression of menstrual fluid prostaglandin F2a, prostaglandin E2, 6-Keto prostaglandin F1a and thromboxane 13, by supro- fen in women with primary dysmcnorrhea[J]. Prosta- glandins Other Lipid Mediat,2007,83(1-2):146-153.
9Dingfelder JR. Primary dysmenorrhea treatment with pros- taglandin and in inhibitors:a review[J]. Am J Obstet Gyne col, 1981,140 (8) : 874-876.
10Richter ON, Tschubel K, Schmolling J, et al. lmmunohistochemical reactivity of myometrigd oxytocin recep tot in extracorporeally perfused nonprcgnant human uteri[J]. Arch Gynecol Obstet,2003,269(1): 6-24.
